Key Highlights
- On November 18, 2026, VisionWave (NASDAQ:VWAV) jumped about 57%, while SeaStar Medical gained roughly 33%, partly undoing sharp declines recorded on November 12.
- After hours VisionWave dropped 18.74% once investors learned that its defence partnerships in Italy, India and Asia carried no customer orders.
- SeaStar Medical's advance had no identified company trigger. Its third-quarter loss of USD 1.03 per share, reported November 11, came in wider than the USD 0.95 forecast.
- Both shares had lost more than 40% on November 12, so even after these gains they sit well below their levels from before that day.
VisionWave: A Rally Followed by a Reversal
VisionWave (NASDAQ:VWAV), which develops defence and security technology including radar and sensing systems, rallied strongly on November 18. The shares had dropped roughly 43% on November 12 after investors questioned the weight of a letter of intent, and the 57% advance claws back part of that fall. No confirmed trigger for the daytime rise was identified, although the company did announce that day its plan to build an international network through defence partnerships in Italy, India and Asia. After the close the stock slid 18.74% as the market focused on the absence of customer orders in those arrangements. The episode underlines a wider point for small defence technology firms: cooperation agreements and memoranda can attract interest, yet investors increasingly want binding contracts with defined revenue. VisionWave's next test is whether these partnerships turn into purchase orders, funded pilot programmes or government contracts. Until then the stock may stay highly volatile, with sharp swings in both directions around each announcement. Its small Market Value also means any Equity raise to fund expansion could weigh heavily on the price, so investors should watch filings as closely as Partnership news.
SeaStar Medical: A Bounce With No Explanation
A medical device maker working on treatments for hyperinflammation in critically ill patients, SeaStar Medical gained roughly 33% on November 18, with no company announcement tied to the move. Shares slid about 48% on November 12, one day after the third-quarter loss of USD 1.03 per share, which was worse than the USD 0.95 consensus, and traders fixated on the cash balance getting smaller. Before that slump the stock sat near USD 1.92, toward the lower end of a 52-week band running from USD 1.84 to USD 5.38, and its market value was only around USD 10 million. Given so small a valuation, even light purchasing can swing the price widely. Earlier steps, including equity sales and executive pay reductions aimed at preserving cash, show how much it depends on outside money. A lasting recovery would probably need evidence of wider product adoption or financing that does not heavily dilute existing holders.
Reading the Rebounds
Recoveries that follow deep sell-offs usually come from short covering and speculative buying, not from a shift in the underlying business. Both names ranked among the biggest losers on November 12, which may have drawn traders hunting for oversold stocks. Broad indices offered scant support: the S&P 500 dropped 0.23%, its fifth consecutive decline, while the Russell 2000 gained 0.46% and small caps held up better, which may have helped speculative names. Caution is warranted. VisionWave's after-hours Reversal shows how quickly gains fade when announcements disappoint, while SeaStar Medical's move has no confirmed trigger. With small market values and limited cash, both companies face a real risk of future share issuance. Investors should track disclosures, contract announcements and financing moves, together with volume, to judge whether buying spreads or dies out after the first surge.
Where Things Stand
The rebounds of 57% for VisionWave (NASDAQ:VWAV) and 33% for SeaStar Medical followed steep November 12 falls, yet VisionWave sank 18.74% after hours over partnerships lacking orders, and SeaStar's rise has no identified cause. Both are very volatile.






Please wait processing your request...